The Trump administration’s December 2025 decision to expedite the reclassification of marijuana from Schedule I to Schedule III under the Controlled Substances Act stands to dramatically alter the landscape of marijuana regulation in the United States. This strategic shift aims to alleviate stringent federal restrictions and diminish the penalties associated with marijuana, according to a White House announcement.
Despite the reclassification, marijuana will still be illegal at the federal level for both medical and recreational purposes. Presently, 40 states and the District of Columbia permit medical marijuana use, while 24 states plus Washington, D.C., allow its recreational use. While the administration highlighted potential benefits for medical research, industry insiders from the marijuana sector celebrated the move for another reason: significant tax savings.
One of the most immediate effects of this reclassification is expected to be tax relief for legal marijuana businesses operating in compliant states.
Understanding the Unique Taxation of Marijuana Businesses
Under current federal law, state-legal marijuana businesses face unique tax challenges.
Typical businesses are allowed to deduct ordinary and necessary expenses, such as rent and utilities. However, this is not the case for businesses dealing with Schedule I and II substances, including marijuana, as outlined in Section 280E of the Internal Revenue Code.
For these businesses, taxes are calculated on their gross income rather than net income. To illustrate, consider a business with $100,000 in income and $80,000 in expenses. A typical business, after deductions, would pay $4,200 in taxes on its net income at a 21% tax rate. Yet, a marijuana business would owe $21,000 in taxes on gross income, resulting in a negative cash flow.
Zamek/VIEWpress/Corbis via Getty Images
This tax predicament is further complicated by historical precedents. In 1927, the Supreme Court ruled that income from illegal activities remains taxable, which later played a role in Al Capone’s conviction for tax evasion. In 1981, the U.S. Tax Court allowed deductions for illegal activities, prompting Congress to enact Section 280E in 1982.
Rescheduling marijuana to Schedule III would eliminate Section 280E’s restrictions, allowing marijuana businesses to operate like other businesses and potentially saving the industry an estimated $2.3 billion, according to industry advocates.
The Subtle Regulatory Role of Taxation
Despite high tax rates, the marijuana industry has thrived, tripling its revenue over the past decade and supporting over 400,000 jobs. Tax laws, however, have subtly influenced how the industry functions.
The current tax code acts as a form of indirect regulation, impacting business operations without directly setting standards or monitoring product potency. Rescheduling would remove this federal influence.
Section 280E affects marijuana businesses in three key ways:
Firstly, it limits financing options by reducing after-tax profits, making internal growth financing challenging. This forces businesses to seek external funding, which can be difficult due to federal restrictions, leading to reliance on private capital with stringent terms.
Secondly, it encourages businesses to separate non-marijuana activities to claim business expense deductions, thus organizing operations into distinct structures.
Lastly, it places importance on accurate accounting for marijuana sales, as businesses can reduce gross income by the direct costs of goods sold, incentivizing meticulous supply chain management.
In sum, federal tax rules serve as a quiet regulatory mechanism that complements state regulations. The debate over rescheduling addresses not only tax normalization and public health risks but also whether the federal government should relinquish its leverage over the legal marijuana industry.
